PRE-FUNDED COMMON STOCK PURCHASE WARRANT CADRENAL THERAPEUTICS, INC.Cadrenal Therapeutics, Inc. • July 14th, 2023 • Pharmaceutical preparations
Company FiledJuly 14th, 2023 IndustryTHIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”), up to _________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 14th, 2023 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJuly 14th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 12, 2023, between Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 14th, 2023 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2023 Company IndustryThis Registration Rights Agreement (this “Agreement”) is made and entered into as of __________, 2023, between Cadrenal Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
LOCK-UP AGREEMENTLock-Up Agreement • July 14th, 2023 • Cadrenal Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 14th, 2023 Company IndustryRe: Securities Purchase Agreement, dated as of July 12, 2023 (the “Purchase Agreement”), between Cadrenal Therapeutics, Inc. (the “Company”) and the purchasers signatory thereto (each, a “Purchaser” and, collectively, the “Purchasers”)